Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP-Reference-Cited by-同舟云学术

Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP

Published:2019-09-10 Issue:52 Volume:10 Page:5403-5411
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kitajima Kazuhiro¹,Okada Masaya²,Yoshihara Kyoko²,Tokugawa Tazuko²,Sawada Akihiro²,Yoshihara Satoshi²,Tamaki Hiroya²,Fujimori Yoshihiro²,Ueda Syuji³,Kawamoto Hiroyuki⁴,Taniguchi Junichi⁵,Yamakado Koichiro⁵

Affiliation:

1. Division of Nuclear Medicine and PET Center, Department of Radiology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

2. Division of Hematology, Departments of Internal Medicine, Transfusion Medicine and Cellular Therapy, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

3. Department of Hematology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan

4. Department of Hematology, Uegahara Hospital, Nishinomiya, Hyogo, Japan

5. Department of Radiology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients;International Journal of Molecular Sciences;2024-08-28

2. Clinical evaluation of deep learning‐enhanced lymphoma pet imaging with accelerated acquisition;Journal of Applied Clinical Medical Physics;2024-05-29

3. Diffuse Large B-Cell Lymphoma Treated With R-CHOP in a Resource-Limited Setting in South Africa: A Real-World Study;The Oncologist;2023-04-13

4. The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review;European Journal of Nuclear Medicine and Molecular Imaging;2022-08-06

5. Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA;Clinical Lymphoma Myeloma and Leukemia;2022-08